Cancer


DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade.

Touat M et al
J Clin Invest. 2018

PDF file fomat icon

PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models.

Guillot C et al
BMC Cancer. 2014

PDF file fomat icon

Functional DNA repair signature of cancer cell lines exposed to a set of cytotoxic anticancer drugs using a multiplexed enzymatic repair assay on biochip.

Forestier A et al
PLoS One. 2012

PDF file fomat icon

Thousands of companies develop genome analysis tools, LXRepair is the only one developing functional comprehensive DNA Repair and DDR assays.

Unleash the potential of your molecules by taking an innovative approach. Be part of the DNA Repair’s revolution.

Make the difference with LXRepair.

Newsletter Signup